X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,450 | -101,167 | -93,867 | -88,696 | -62,131 |
| Depreciation Amortization | 796 | 419 | 513 | 10,257 | 351 |
| Accounts receivable | -1,070 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -286 | 1,234 | 3,425 | 1,166 | 1,031 |
| Other Working Capital | 2,675 | 344 | 5,736 | -1,498 | -4,063 |
| Other Operating Activity | -95,566 | 2,658 | 7,091 | 7,866 | 5,994 |
| Operating Cash Flow | $-130,901 | $-96,512 | $-77,102 | $-70,905 | $-58,818 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 104,674 | -60 | -103 | -615 | -1,362 |
| Purchase Of Investment | -57,134 | -16,823 | 0 | 0 | N/A |
| Sale Of Investment | 26,450 | 2,000 | 0 | 0 | N/A |
| Purchase Sale Intangibles | -7,000 | 0 | 0 | N/A | N/A |
| Other Investing Activity | -7,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $66,990 | $-14,883 | $-103 | $-615 | $-1,362 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 20,000 | 22,500 | N/A | N/A | 12,388 |
| Debt Repayment | 0 | -2,064 | -795 | 0 | 0 |
| Common Stock Issued | 294 | 68,711 | 122,839 | 76,245 | 284 |
| Common Stock Repurchased | N/A | N/A | N/A | -2,000 | N/A |
| Other Financing Activity | 0 | -631 | -4,814 | 0 | -278 |
| Financing Cash Flow | $20,294 | $88,516 | $117,230 | $74,245 | $12,394 |
| Exchange Rate Effect | -156 | 99 | -105 | -319 | 402 |
| Beginning Cash Position | 100,248 | 123,028 | 83,108 | 80,702 | 128,086 |
| End Cash Position | 56,475 | 100,248 | 123,028 | 83,108 | 80,702 |
| Net Cash Flow | $-43,773 | $-22,780 | $39,920 | $2,406 | $-47,384 |
| Free Cash Flow | |||||
| Operating Cash Flow | -130,901 | -96,512 | -77,102 | -70,905 | -58,818 |
| Capital Expenditure | -326 | -60 | -103 | -615 | -1,362 |
| Free Cash Flow | -131,227 | -96,572 | -77,205 | -71,520 | -60,180 |